The candidates vying to be the next London mayor
Enfield Council commits to anti-racism and diversity pledge
President Erdogan promised supporters his party would learn its lessons from the defeat
Mayor of London and London Assembly elections
UK and US scientists have been working on eclipse observations
Unsupportive goverment policies jeopardizing foundation of UK food security
UK Visas and Immigration UKVI are developing a digital immigration system named eVisa
Oppenheimer sweeps awards with best picture and actor wins, Oscars 2024
English Premier League leaders Arsenal will visit title contenders
Liverpool meet Atalanta and West Ham face Bayer Leverkusen
Arsenal face Bayern Munich and Manchester City play Real Madrid
UK Transfer deadline day, the transfer window closes tonight
Europe's travel strikes: Flight and train disruption you can expect in April
Enfield Council website achieves digital inclusion recognition
Enfield Council’s Planning Enforcement team goes from strength to strength
UK's first Turkish Shacklewell Lane Mosque faces threat to its future
Intermune, which is based in Brisbane, California, makes a medicine for idiopathic pulmonary fibrosis, a deadly disease which scars the lungs. The deal is the latest in a string of mergers in the drugs sector. It is also the largest by Roche since 2009 when it bought the remainder of Genentech for about $47bn. Roche will pay $78 per share in InterMune, which is a premium of 38% on top of the value of the shares at the end of last week. Recent deals in the drug sector include US drug firm AbbVie's purchase of the UK pharmaceutical company Shire for £32bn. UK High Street chemist Alliance Boots was bought up by US pharmacy giant Walgreens in an agreement earlier this month. In May, pharmaceutical company Pfizer dropped a bid for UK company AstraZeneca.
bbc
